-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

2154 Prevalence of Extramedullary Hematopoiesis, Vertebral, Hepatic and Splenic Hemangioma and Renal Cyst Among Thalassaemic Patients: A Retrospective Study from the Myocardial Iron in Thalassemia (MIOT) NetworkClinically Relevant Abstract

Thalassemia and Globin Gene Regulation
Program: Oral and Poster Abstracts
Session: 112. Thalassemia and Globin Gene Regulation: Poster II
Sunday, December 6, 2015, 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Alessia Pepe1*, Antonella Meloni1*, Alessandra Briatico Vangosa2*, Fabrizia Terrazzino3*, Maria Giovanna Neri1*, Domenico Maddaloni4*, Gaetano Roccamo5*, Sabrina Armari6*, Aurelio Maggio, MD7, Cristina Salvatori8*, Vincenzo Positano1* and Paolo Ricchi9*

1CMR Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
2Institute of Radiology, “G. D’Annunzio” University, Chieti, Italy
3Unità Operativa Complessa Radiologia, “ARNAS” Civico, Palermo, Italy
4Unità Operativa Complessa di Pediatria, Ospedale "Engles Profili", Fabriano, Italy
5Unità di Prevenzione e Cura delle Mictrocitemie, Ospedale "Civile", S. Agata di Militello (ME), Italy
6Reparto di Pediatria, Azienda Ospedaliera di Legnago, Legnago (VR), Italy
7Dept. of Hematology, Hospital 'V. Cervello', Palermo, Italy
8Unità Operativa Sistemi Informatici, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
9Unità Operativa Semplice Dipartimentale Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale, Napoli, Italy

BACKGROUND: The prevalence and the clinical relevance of several extracardiac findings (EF) at Magnetic Resonance Imaging (MRI) have been recently estimated in cohorts of non thalassaemic patients.

AIM: In this study we sought to determine the prevalence of EF potentially related to anaemia and ipoxia in age- and sex- matched populations with thalassaemia major (TM) and Thalassaemia Intermedia (TI).

METHODS: We retrospectively considered 159 TM patients regularly transfused (73 F; 34±9.20 years) and 159 TI patients (73 F; 34±9.18 years) consecutively enrolled in the Myocardial Iron in Thalassemia (MIOT) Network to quantify cardiac and liver iron by T2* technique. Patients with TI were further subdivided in non transfusion dependent (NTD-TI)  and transfusion dependent (TD-TI). All MRI images were used to assess the presence or absence of Extramedullary Hematopoiesis (EMH), kidney, splenic and liver cysts, and vertebral  hemangiomas.

RESULTS:  Overall, EF were detected in 33% and 26% of patients with TI and TM, respectively. Table 1 shows the comparison of MRI data between TM and TI patients. Both groups of patients had elevated but comparable prevalence of kidney, splenic and liver cysts and vertebral  haemangiomas. TI patients were found to have significant higher EMH as compared to TM. The prevalence of total EF increased with advancing age and renal cysts were found in the 28.6% of the cohort aged 45-55 years. Patients with renal cysts had comparable serum creatinin level with respect to those without. Within the population of TI-TD it was observed the highest prevalence of patients with renal cysts, splenic cyst and vertebral haemangioma (26%, 3% and 3%, respectively).  

Thalassemic patients had a was significant higher prevalence of renal cysts than the general population (19.2 vs 7.8%; P<0.0001).

CONCLUSIONS: EF are well-recognized features in patients undergoing MRI, being hepatic cysts or hemangiomas and renal cyst the most frequently observed. Our data on hemangiomas and renal cysts, particularly among patients with TI-TD, indicate a significant higher prevalence of EF compared to the general population. These data seem to suggest the role of the inappropriate activation of the Hypoxia-Inducible Factor (HIF) system linked to the chronic hypoxia as observed in the Chuvash polycythemia or in the the von Hippel-Lindau (VHL) syndrome. Furthermore, HIF in general population has been directly involved in the development and/or progression of clear cell renal cancer also described among thalassemic patients.

 

Disclosures: Pepe: Chiesi: Speakers Bureau ; ApoPharma Inc: Speakers Bureau ; Novartis: Speakers Bureau .

*signifies non-member of ASH